Press Releases

Optical configurations meet needs of any lab, research discipline or individual application Product can detect up to 14 parameters from a single sample Merck, a leading science and technology company, is expanding its popular...

Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May 23 in New York, NY. Jay Saccaro, corporate vice president and chief financial officer, is scheduled to present at 9:00 a.m. (CDT). ...

Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany. Innovations...

Merck, a leading science and technology company, today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers. The assay is intended for research use only, not for use in diagnostic procedures. ...

Phase III study met all co-primary and secondary endpoints and achieved statistically significant resultsWorld pharma today/-press releases/-Allergan Plc and Gedeon Richter Plc. announced positive results from Venus I, one of two pivotal Phase III clinical trials evaluating the efficacy...

AbbVie a global biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA® (ibrutinib) Prescribing Information (PI) to include new data from two Phase 3 trials supporting its expanded use in patients with chronic lymphocytic leukemia...

With unprecedented levels of rail investment and the rise of national infrastructure up the political agenda, there was an upbeat mood at the Infrarail 2016 exhibition of railway infrastructure products and services and at CITE 2016, covering the civil...